(Press-News.org) Using "mini-brains" built with induced pluripotent stem cells derived from patients with a rare, but devastating, neurological disorder, researchers at University of California, San Diego School of Medicine say they have identified a drug candidate that appears to "rescue" dysfunctional cells by suppressing a critical genetic alteration.
Their findings are published in the September 8 online issue of Molecular Psychiatry.
The neurological disorder is called MECP2 duplication syndrome. First described in 2005, it is caused by duplication of genetic material in a specific region of the X chromosome that encompasses MECP2 and adjacent genes. The disorder displays a wide variety of symptoms, among them low muscle tone, developmental delays, recurrent respiratory infections, speech abnormalities, seizures, autistic behaviors and potentially severe intellectual disability.
It is heritable, but can also occur randomly. MECP2 duplication syndrome occurs almost exclusively in males. A similar disorder known as Rett (RTT) Syndrome, which involves MECP2 gene deletions, primarily affects females. Current treatment is largely symptomatic, involving therapies, drugs and surgeries that address specific issues.
As in previous, ground-breaking research with Rett Syndrome patients, senior author Alysson Muotri, PhD, associate professor in the UC San Diego departments of Pediatrics and Cellular and Molecular Medicine, and colleagues took skin cells from MECP2 duplication patients, converted them into induced pluripotent stem cells (iPSC), then programmed the stem cells to become neurons that recapitulate the disorder more robustly than existing mouse models.
Muotri said analyses of the iPSC-derived neurons revealed novel molecular and cellular phenotypes, including an over-synchronization of the neuronal networks. Interestingly, these phenotypes go in a direction opposite of what scientists had previously reported for Rett syndrome, suggesting that the correct gene dosage is important for homeostasis in human neurons. More importantly, said Muotri, the finding with human neurons helped direct the next stage, a drug screening, which uncovered a drug candidate - a histone deacetylase inhibitor that reversed all the MECP2 alterations in the mutant neurons, with no harm to control neurons.
"This work is encouraging for several reasons," said Muotri. "First, this compound had never before been considered a therapeutic alternative for neurological disorders. Second, the speed in which we were able to do this. With mouse models, this work would likely have taken years and results would not necessarily be useful for humans."
Muotri said the findings further underscore the potential of stem cell-based models as an efficient method for screening potential drug libraries for the ability to rescue human neuronal phenotypes in a dish. He said his research team would be concluding its preclinical studies in preparation for moving into clinical trials as soon as possible.
INFORMATION:
Co-authors include Savitha Nageshappa, KU Leuven Center for Human Genetics, Belgium; Cassiano Carromeu, Cieber A. Trujillo, Pinar Mesci, Bruno H.S. Araujo and Laila B. Torres, UCSD and Rady Children's Hospital-San Diego; Ira Espuny-Camacho, Universite Libre de Bruxelles and VIB Center for the Biology of Disease, Belgium; Emanuela Pasciuto, VIB Center for the Biology of Disease and KU Leuven Center for Human Genetics, Belgium; Pierre Vanderhaeghen, Universite Libre de Bruxells, VIB Center for the Biology of Disease and WELBIO, Belgium; Catherin Verfaillie and Susanna Raitano, KU Leuven Medical School, Belgium and Manipal Institute of Regenerative Medicine, India; Claudia M.B. Carvalho, Baylor College of Medicine, Texas and FIOCRUZ, Brazil; Claudia Bagni, VIB Center for the Biology of Disease, KU Leuven Center for Human Genetics, Belgium and University of Rome Tor Vergata, Italy; Melissa B. Ramocki, and James R. Lupski, Baylor College of Medicine, Texas; and Hilde Van Esch, KU Leuven Center for Human Genetics and University Hospitals Leuven, Belgium.
Funding for this research came, in part, from the California Institute for Regenerative Medicine, the National Institutes of Health (grants 1-DP2-OD006495-01 and R01MH094753), the International Rett Syndrome Foundation, NARSAD, National Institute of Neurological Disorders and Stroke (grant K08 NS062711), the Fonds voor Wetenschappelijk Onderzoek, Viaanderen and Fondation Jerome Lejeune.
ALEXANDRIA, VA--The latest research on hearing loss, head and neck cancers, sleep apnea and other otolaryngic topics will be presented in Dallas, TX, September 27-30, at the 2015 Annual Meeting & OTO EXPO? of the American Academy of Otolaryngology--Head and Neck Surgery Foundation (AAO-HNSF), the largest annual meeting of ear, nose, throat, head and neck physicians in the world.
Abstracts of the research to be presented are now available online at http://oto.sagepub.com/content/153/1_suppl.toc. The 2015 Annual Meeting features more than 380 oral and 180 poster presentations ...
ATLANTA - September 8, 2015-New American Cancer Society Cancer Survivorship Care guidelines released today provide primary care clinicians with recommendations for providing comprehensive care to the estimated 1.2 million survivors of colorectal cancer in the United States.
The guidelines are the second to be published in a series of cancer survivorship care guidelines developed by the American Cancer Society. They provide guidance on identifying and managing potential physical and psychosocial long-term and late effects of colorectal cancer and its treatment, as well ...
PITTSBURGH, Sept. 8, 2015 - Young people across the United States who smoke electronic cigarettes are considerably more likely to start smoking traditional cigarettes within a year than their peers who do not smoke e-cigarettes, according to an analysis led by the University of Pittsburgh Center for Research on Media, Technology, and Health (CRMTH) and the Dartmouth-Hitchcock Norris Cotton Cancer Center. The study, funded by the National Cancer Institute (NCI), was the first to assess this relation in a national U.S. sample of youth, and to include people older than 18 ...
Continued smoking after a diagnosis of multiple sclerosis (MS) appears to be associated with accelerated disease progression compared with those patients who quit smoking, according to an article published online by JAMA Neurology.
MS is a neurogenerative disease and smoking is one of its known risk factors. While MS begins with an initial course of irregular and worsening relapses, it usually changes after about 20 years into secondary progressive (SP) disease. The time from onset to conversion to SPMS is a frequently used measure of disease progression.
Jan Hillert, ...
About one-third of girls and boys who survived child trafficking experienced physical and/or sexual violence during their ordeal in a study of children receiving posttrafficking services in Cambodia, Thailand and Vietnam, according to an article published online by JAMA Pediatrics.
Many of these survivors of child trafficking in the Greater Mekong Subregion of Southeast Asia screened positive for depression, anxiety and posttraumatic stress disorder (PTSD), and mental health symptoms were associated with self-harm and suicide ideation, according to the article.
Millions ...
A new study of U.S. adolescents and young people suggests that using electronic cigarettes was associated with progression to traditional cigarette smoking, according to an article published online by JAMA Pediatrics.
Some studies suggest e-cigarettes may help smokers reduce the use of traditional tobacco products. Still, there is concern that e-cigarette marketing could position the product to recruit nonsmokers and the use of e-cigarettes has increased among both adolescents and young adults.
Brian A. Primack, M.D., Ph.D., of the University of Pittsburgh School of ...
The California Public Employees' Retirement System (CalPERS) saved $7 million on spending for colonoscopy two years after it implemented a reference payment initiative that offered full insurance coverage at low-priced facilities but required substantial cost sharing if patients picked a high-priced alternative, according to an article published online by JAMA Internal Medicine.
Some employers are experimenting with payment methods that seek to counter high health care prices while upholding consumer access to valuable services. Employers, insurers and consumers face ...
In 2011-2012, the estimated prevalence of diabetes among U.S. adults was 12 percent to 14 percent and the prevalence of prediabetes was 37 percent to 38 percent, indicating that about half of the U.S. adult population has either diabetes or prediabetes, according to a study in the September 8 issue of JAMA. Though data from recent years suggests that the increasing prevalence of diabetes may be leveling off.
Diabetes is a major cause of illness and death in the United States, costing an estimated $245 billion in 2012 due to increased use of health resources and lost productivity. ...
Over the last 20 years, complications have decreased and survival has improved for extremely preterm infants, according to a study in the September 8 issue of JAMA.
Advances in medicine over the past 2 decades have changed care for mothers in preterm labor and for extremely preterm infants. Evaluation of current in-hospital complications and mortality data among extremely preterm infants is important in counseling families and considering new interventions to improve outcomes. Barbara J. Stoll, M.D., of the Emory University School of Medicine, Atlanta, and colleagues ...
Among women in a malaria-endemic region in Kenya, daily iron supplementation during pregnancy did not result in an increased risk of malaria, according to a study in the September 8 issue of JAMA. Iron supplementation did result in increased birth weight, gestational duration, neonatal length, and a decreased risk of low birth weight and prematurity.
Anemia in pregnancy is a moderate or severe health problem in more than 80 percent of countries worldwide, but particularly in Africa, where it affects 57 percent of pregnant women. Iron deficiency is the most common cause, ...
